Markus Möbs

1.4k citations
42 papers · 802 indexed · h-index 19

Markus Möbs

39 papers receiving 794 citations

Peers

Markus Möbs
Comparison fields: 5 of 68
  • Dermatology 239
  • Pathology and Forensic Medicine 250
  • Immunology 240
  • Oncology 303
  • Cancer Research 116
Replace Kedar Inamdar with:
Kedar Inamdar United States
John R. Spaull United Kingdom
Lorenza Pastorino Italy
Barbara MacGregor‐Cortelli United States
D C Louie United States
Feifei Nan China
A Rosolen Italy
Jena D. French United States
J.‐P. Magaud France
Sébastien de Feraudy United States
Markus Möbs relative to Kedar Inamdar United States Kedar Inamdar's profile →
Citations per field
00.5×3.6×
Kedar Inamdar · 1×
Citations per year

Countries citing papers authored by Markus Möbs

Since Specialization
Citations

This map shows the geographic impact of Markus Möbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Möbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Möbs more than expected).

Fields of papers citing papers by Markus Möbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Möbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Möbs. The network helps show where Markus Möbs may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Markus Möbs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Möbs Line = papers co-authored together Markus Möbs links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20252
3 20240
4 20233
5 20212
6 202123
7 202028
8 201854
9 20187
10 201728
11 201712
12 201613
13 201626
14 201518
15 201417
16 201422
17 20131
18 20138
19 201137
20 201023

About Markus Möbs

Markus Möbs is a scholar working on Dermatology, Pathology and Forensic Medicine and Immunology, having authored 42 papers that have together received 802 indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (22 papers), Lymphoma Diagnosis and Treatment (15 papers), T-cell and Retrovirus Studies (9 papers), Chronic Lymphocytic Leukemia Research (4 papers), Fungal Infections and Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers) and Dermatology and Skin Diseases (3 papers). The work is most often cited by research in Dermatology (239 citations), Pathology and Forensic Medicine (250 citations) and Immunology (240 citations). Markus Möbs has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Wolfram Sterry, Chalid Assaf, Marc Beyer, Daniel Humme, Jürgen Eberle, Frank Braun, Michael Hummel, Nadya Al‐Yacoub, Michael Plötz and Karin Müller‐Decker. Their work appears in journals such as Journal of Investigative Dermatology, JDDG Journal der Deutschen Dermatologischen Gesellschaft, Journal of Molecular Diagnostics, Leukemia and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026